How do you test for hypoparathyroidism?

Testing for Hypoparathyroidism

Diagnose hypoparathyroidism by measuring albumin-corrected or ionized calcium (confirmed on two separate occasions at least two weeks apart) alongside inappropriately normal or low PTH levels using a 2nd or 3rd generation assay. 1

Core Diagnostic Tests

The biochemical diagnosis requires demonstrating:

• Low serum calcium (albumin-corrected or ionized)

  • Must be confirmed on two separate occasions
  • Measurements should be at least two weeks apart 1

• Inappropriately normal or low PTH

  • Use 2nd or 3rd generation PTH assay 1, 2
  • These "two-site" assays avoid interference from inactive PTH fragments 2
  • PTH should be undetectable or inappropriately low given the hypocalcemia 2

Context-Specific Testing Approaches

Postsurgical Hypoparathyroidism

Measure PTH 12-24 hours after total thyroidectomy 1:

• PTH >10 pg/mL (1.05 pmol/L): Patient unlikely to develop permanent hypoparathyroidism
• PTH <10 pg/mL (<1.05 pmol/L): Close follow-up required
  • Recheck calcium and PTH within first week post-surgery
  • Earlier if symptoms or severe hypocalcemia present
  • Less than 50% will develop permanent hypoparathyroidism 1

Chronic postsurgical hypoparathyroidism is confirmed ≥12 months after surgery when hypocalcemia persists with inappropriately normal or low PTH 1, 3, 4

Nonsurgical Hypoparathyroidism

Beyond the core calcium and PTH measurements 1:

• Check serum magnesium and correct if abnormal (magnesium deficiency causes PTH resistance and can falsely suggest hypoparathyroidism) 1

• Stop biotin supplementation (if >5 mg daily) for at least 3 days before testing, as it interferes with some PTH assays 1

• Genetic testing is advised for:

  • All patients with idiopathic hypoparathyroidism
  • Especially those with family history
  • Those under age 40 years 1, 3, 5

Critical Testing Pitfalls

Magnesium must be checked and normalized before confirming hypoparathyroidism—low magnesium causes PTH resistance (magnesium is a cofactor for adenylate cyclase), while high magnesium suppresses PTH secretion by binding to the calcium-sensing receptor 1. This can mimic true hypoparathyroidism.

Biotin interference is a real concern with high-dose supplementation (>5 mg daily), as it can falsely lower PTH results in certain assays 1. Always ask about biotin use and discontinue before testing.

PTH assay generation matters: Second-generation assays (measuring "intact PTH") are most widely used and provide excellent discrimination. Third-generation assays measure PTH(1-84) more exclusively but offer minimal clinical advantage over second-generation assays in practice 2, 6. Either is acceptable, but subsequent measurements should use the same assay for consistency 6.

Additional Baseline Assessments

Once hypoparathyroidism is confirmed, evaluate for complications 1:

• Renal: 24-hour urine for calcium, creatinine, oxalate, citrate; eGFR; renal ultrasound
• Ocular: Eye exam for cataracts
• Cardiac: EKG (especially with symptoms or significant hypocalcemia)
• Skeletal: Bone turnover markers, BMD with DXA
• Neurologic: Brain CT if neuropsychiatric symptoms present and disease duration >5 years
• Psychiatric: Screen for depression and anxiety

The diagnosis is straightforward when you find hypocalcemia with inappropriately low PTH, but the key is confirming it properly (two separate occasions, weeks apart) and ruling out magnesium abnormalities and biotin interference before labeling someone with this chronic condition.